New vaccine support (NVS) for IPV

GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems.

Project ID
47122-1518-LBR-25C-X
Activity status
2 - Implementation
Aid type
B02 - Core contributions to multilateral institutions
% to Liberia
100.00

Organisations

Funding
The Global Alliance for Vaccination and Immunisation
Extending
World Health Organisation - core voluntary contributions account (for technical assitance)
Accountable
Federal States & Local Governments
Implementing
Federal States & Local Governments
Extending
United Nations Childrens Fund

Disbursements by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Liberia Value (USD)
2018 Q1 54,347.00 54,347.00
2017 Q4 52,488.00 52,488.00
2017 Q3 54,603.00 54,603.00
2017 Q2 51,707.00 51,707.00
2017 Q1 14,500.00 14,500.00
2016 Q4 54,144.00 54,144.00
2016 Q3 -342.00 -342.00
2015 Q4 -312,783.00 -312,783.00
2014 Q1 326,193.00 326,193.00

Commitments by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Liberia Value (USD)
2017 Q2 188,071.00 188,071.00
2016 Q4 13,658.00 13,658.00
2016 Q2 -312,783.00 -312,783.00
2016 Q1 57,500.00 57,500.00
2015 Q2 -25,807.00 -25,807.00
2013 Q4 352,000.00 352,000.00

MTEF projections by fiscal year

Fiscal year Value (USD) Liberia Value (USD)
2016 144,750.00 144,750.00
2015 320,750.00 320,750.00
2014 176,000.00 176,000.00

CRS code %
Infectious disease control (12250) 100.0